Jay Yates, MD
Otolaryngology · Sulphur Springs, TXNPI 1902820970
Payments from drug & device makers
Across 41 payments — averaging $130.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intersect ENT, Inc.$3K
- Medtronic$605
- Aerin Medical Inc.$602
- Intuitive Surgical$285
- Integra Lifesciences Corporation$281
- Sanofi$128
- plus $376 from 5 others
What the payments were for
- Travel & lodging$2,76952%
- Food & beverage$2,58648%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intersect ENT, Inc. | 7 | $3,078 |
| Medtronic(2 entities) | 12 | $605 |
| Aerin Medical Inc. | 9 | $602 |
| Intuitive Surgical | 3 | $285 |
| Integra Lifesciences Corporation | 2 | $281 |
| Sanofi | 1 | $128 |
| Stryker | 1 | $114 |
| Inspire Medical Systems, Inc. | 3 | $107 |
| Optinose US, Inc. | 1 | $106 |
| Pfizer | 1 | $32 |
| Baxter Healthcare | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROPEL$3,078
- SINUVA$2,928
- Acclarent Aera$281
- Inspira Air$281
- RELIEVA SPINPLUS NAV$281
- TruDi Probe$281
- VIVAER STYLUS$223
- RHINAER STYLUS$223
- Da Vinci Surgical System$210
- FUSION$163
- DUPIXENT$128
- ENTELLUS - ENTELLUS MEDICAL REINFORCED ANESTHESIA NEEDLE$114
- Xhance$106
How this compares
$5,355 in reported general payments places this provider in the 75th percentile of 729 otolaryngology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 571 | $7,721 |
| Epinephrine | 13 | $3,307 |
| SynthroidLevothyroxine Sodium | 56 | $2,947 |
| Mometasone Furoate | 24 | $2,007 |
| Dexamethasone | 16 | $1,122 |
| Ofloxacin | 41 | $1,023 |
| CefuroximeCefuroxime Axetil | 54 | $871 |
| Fluticasone Propionate | 61 | $770 |
| Azelastine Hcl | 15 | $334 |
| Fluocinolone Acetonide | 14 | $254 |
| Levocetirizine Dihydrochloride | 22 | $72 |
| Tramadol Hcl | 11 | $15 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Sulphur Springs
- Laurence ChuAustin$37.4M
- Mark ZafereoHouston$7.8M
- Neil GrossHouston$1.5M
- Chad McDuffieFrisco$1.5M
- Ian AlexanderBoerne$999K
- Stephen LaiHouston$968K
- Benjamin CilentoSpring$963K
- Amber LuongHouston$793K
- Jeffrey RosenbloomSan Antonio$720K
- Masayoshi TakashimaHouston$644K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.